ERLEADA
Drug timelines are a Plus or Pro feature.
48 regulatory and trial events tracked for ERLEADA, covering 2016-11-22 to 2026-04-22. Get the full timeline:
Most recent: EMA Authorised: Erleada (apalutamide) — Janssen-Cilag International NV